Risk Prediction and Right Ventricular Dilation in a Single-Institution Pulmonary Arterial Hypertension Cohort.
作者信息
Pi Hongyang, Carlson Selma D, Barros Lia M, Hogl Laurie, Kirkpatrick James N, Nolley Stephanie, Ralph David D, Rayner Samuel G, Leary Peter J
机构信息
Department of Medicine University of Washington Seattle WA.
Department of Medicine Veterans Administration Minneapolis Minneapolis MN.
出版信息
J Am Heart Assoc. 2022 Jul 19;11(14):e025521. doi: 10.1161/JAHA.122.025521. Epub 2022 Jul 13.
Abstract
摘要
相似文献
1
Risk Prediction and Right Ventricular Dilation in a Single-Institution Pulmonary Arterial Hypertension Cohort.单中心肺动脉高压队列中的风险预测与右心室扩张
J Am Heart Assoc. 2022 Jul 19;11(14):e025521. doi: 10.1161/JAHA.122.025521. Epub 2022 Jul 13.
2
Right Ventricular Imaging for Predicting Risk in Pulmonary Arterial Hypertension: The Elephant in the Room.右心室成像预测肺动脉高压风险：被忽视的重要问题。
Chest. 2023 May;163(5):1013-1015. doi: 10.1016/j.chest.2023.02.039.
3
CT signs of right ventricular dysfunction correlated with echocardiography-derived pulmonary arterial systolic pressure: incremental value of the pulmonary arterial diameter index.CT 征象与超声心动图估测的肺动脉收缩压右心功能相关性：肺动脉直径指数的附加价值。
Int J Cardiovasc Imaging. 2013 Dec;29 Suppl 2:109-18. doi: 10.1007/s10554-013-0322-7. Epub 2013 Nov 6.
4
Reply to: Correlation Between Right Ventricular Echocardiography Measurements and Functional Capacity in Patients With Pulmonary Arterial Hypertension.回复：肺动脉高压患者右心室超声心动图测量值与功能容量之间的相关性
Tex Heart Inst J. 2024 Jun 5;51(1). doi: 10.14503/THIJ-24-8451.
5
The importance of right ventricular remodelling in pulmonary arterial hypertension.右心室重塑在肺动脉高压中的重要性。
Heart. 2022 Aug 11;108(17):1338-1339. doi: 10.1136/heartjnl-2022-321143.
6
Imaging in pulmonary hypertension: Focus on the role of echocardiography.肺动脉高压的影像学检查：聚焦超声心动图的作用
Arch Cardiovasc Dis. 2014 Apr;107(4):261-71. doi: 10.1016/j.acvd.2014.02.005. Epub 2014 Apr 18.
7
New Tricks for an Old Drug: Prostacyclins and Right Ventricular Contractility in Pulmonary Arterial Hypertension.老药新用：前列环素与肺动脉高压中的右心室收缩功能
Am J Respir Crit Care Med. 2022 Jul 1;206(1):12-13. doi: 10.1164/rccm.202204-0648ED.
8
Evaluation of right ventricular function in patients with pulmonary arterial hypertension by different right ventricular-pulmonary artery coupling methods.不同右心室-肺动脉耦合方法评估肺动脉高压患者右心室功能。
Medicine (Baltimore). 2022 Sep 30;101(39):e30873. doi: 10.1097/MD.0000000000030873.
9
Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.系统性硬化症相关肺动脉高压与特发性肺动脉高压治疗中右心室功能变化的差异。
Ann Am Thorac Soc. 2017 May;14(5):682-689. doi: 10.1513/AnnalsATS.201608-655OC.
10
Echocardiographic assessment of right ventricular function: how to account for tricuspid regurgitation and pulmonary hypertension.右心室功能的超声心动图评估：如何考虑三尖瓣反流和肺动脉高压
JACC Cardiovasc Imaging. 2012 Jul;5(7):747-53. doi: 10.1016/j.jcmg.2011.08.026.
引用本文的文献
1
Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension: A Randomized Controlled Trial.法莫替丁对肺动脉高压患者预后的影响：一项随机对照试验。
Chest. 2025 Jul;168(1):189-199. doi: 10.1016/j.chest.2024.12.029. Epub 2025 Jan 4.
2
Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension.肺动脉高压右心室结局的蛋白质组学特征
Circ Heart Fail. 2024 Nov;17(11):e012067. doi: 10.1161/CIRCHEARTFAILURE.124.012067. Epub 2024 Oct 22.
3
Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review.连续风险分层对成人和儿科肺动脉高压的预后价值：系统评价。
J Am Heart Assoc. 2024 Jul 2;13(13):e034151. doi: 10.1161/JAHA.123.034151. Epub 2024 Jun 21.
4
Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes.与肺动脉高压结局相关的代谢组学特征。
Circ Res. 2023 Feb 3;132(3):254-266. doi: 10.1161/CIRCRESAHA.122.321923. Epub 2023 Jan 4.
本文引用的文献
1
Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score.功能性 II 级肺动脉高压患者的风险评估：医生整体评估与 ESC/ERS 和 REVEAL 2.0 风险评分的比较。
PLoS One. 2020 Nov 11;15(11):e0241504. doi: 10.1371/journal.pone.0241504. eCollection 2020.
2
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.预测肺动脉高压患者的生存情况：REVEAL 风险评分计算器 2.0 与 ESC/ERS 风险评估策略的比较。
Chest. 2019 Aug;156(2):323-337. doi: 10.1016/j.chest.2019.02.004. Epub 2019 Feb 14.
3
Risk assessment in pulmonary arterial hypertension.肺动脉高压的风险评估
Eur Respir J. 2018 Mar 29;51(3). doi: 10.1183/13993003.00279-2018. Print 2018 Mar.
4
The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?肺动脉高压的低风险特征。是时候向以目标为导向的临床试验终点进行范式转变了吗？
Am J Respir Crit Care Med. 2018 Apr 1;197(7):860-868. doi: 10.1164/rccm.201709-1840PP.
Zotero 插件